Redhill Biopharma
RDHL
22 hedge funds and large institutions have $24.9M invested in Redhill Biopharma in 2016 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 1 reducing their positions, and 3 closing their positions.
800% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 1
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
5% more funds holding
Funds holding: 21 → 22 (+1)
0% more ownership
Funds ownership: 0% → 0% (+0%)
9% less capital invested
Capital invested by funds: $27.3M → $24.9M (-$2.39M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MIFH
Migdal Insurance & Financial Holdings
Petach Tikva,
Israel
|
+$4.69M |
| 2 |
MMH
Menora Mivtachim Holdings
Ramat Gan,
Israel
|
+$2.1M |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
+$1.53M |
| 4 |
NC
Nexthera Capital
New York
|
+$1.14M |
| 5 |
BHB
Bank Hapoalim BM
Tel Aviv,
Israel
|
+$551K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Broadfin Capital
New York
|
-$5.57M |
| 2 |
FAM
Fred Alger Management
New York
|
-$299K |
| 3 |
FM
Family Management
New York
|
-$229K |
| 4 |
WA
WFG Advisors
Dallas,
Texas
|
-$10K |
| 5 |
AIM
Acrospire Investment Management
Chicago,
Illinois
|
-$6K |
RDHL Hedge Fund Activity: Q4 2016 in Review
22 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Redhill Biopharma (RDHL) for Q4 2016, worth a combined $24.9M — down 8.8% from $27.3M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new RDHL positions and 3 closed out — a net gain of 1 holder — while 9 added to existing stakes and 1 trimmed.
The largest buyer was Migdal Insurance & Financial Holdings, opening a new position worth an estimated $4.69M. The largest seller was Broadfin Capital, cutting an estimated $5.57M.
- 22 institutional investors held Redhill Biopharma (RDHL) as of Q4 2016, up from 21 in Q3 2016.
- Funds reported $24.9M of Redhill Biopharma stock for Q4 2016, down 8.8% quarter-over-quarter.
- 4 funds opened new Redhill Biopharma positions in Q4 2016 and 3 closed out, a net change of +1 holder.
- The largest Redhill Biopharma buyer in Q4 2016 was Migdal Insurance & Financial Holdings, an estimated $4.69M added.
- The largest Redhill Biopharma seller in Q4 2016 was Broadfin Capital, an estimated $5.57M sold.
Based on aggregated 13F filings for Q4 2016.